These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24488582)

  • 1. Comparison of the efficacy of micronized progesterone and lynestrenol in treatment of simple endometrial hyperplasia without atypia.
    Tasci Y; Polat OG; Ozdogan S; Karcaaltincaba D; Seckin L; Erkaya S
    Arch Gynecol Obstet; 2014 Jul; 290(1):83-6. PubMed ID: 24488582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia.
    Ozdegirmenci O; Kayikcioglu F; Bozkurt U; Akgul MA; Haberal A
    Gynecol Obstet Invest; 2011; 72(1):10-4. PubMed ID: 21266792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.
    Uysal G; Acmaz G; Madendag Y; Cagli F; Akkaya H; Madendag I; Karakilic EU
    Gynecol Obstet Invest; 2018; 83(2):151-155. PubMed ID: 28715800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia.
    Ismail MT; Fahmy DM; Elshmaa NS
    Reprod Sci; 2013 Jan; 20(1):45-50. PubMed ID: 23203322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of simple and complex endometrial non-atypical hyperplasia with natural progesterone: response rate to different doses.
    Marra C; Penati C; Ferrari L; Cantù MG; Bargossi L; Fruscio R
    Gynecol Endocrinol; 2014; 30(12):899-901. PubMed ID: 25111756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia.
    Bese T; Vural A; Ozturk M; Dagistanli F; Demirkiran F; Tuncdemir M; Arvas M; Sanioglu C; Kosebay D
    Int J Gynecol Cancer; 2006; 16(2):809-13. PubMed ID: 16681766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study.
    Emarh M
    Arch Gynecol Obstet; 2015 Dec; 292(6):1339-43. PubMed ID: 26015309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
    Gong Q; Chen X; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
    Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
    Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial hyperplasia with secretory changes.
    Tresserra F; Lopez-Yarto M; Grases PJ; Ubeda A; Pascual MA; Labastida R
    Gynecol Oncol; 2003 Mar; 88(3):386-93. PubMed ID: 12648591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone.
    Affinito P; Di Carlo C; Di Mauro P; Napolitano V; Nappi C
    Maturitas; 1994 Dec; 20(2-3):191-8. PubMed ID: 7715472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
    Kim MK; Seong SJ; Lee TS; Ki KD; Lim MC; Kim YH; Kim K; Joo WD
    Jpn J Clin Oncol; 2015 Oct; 45(10):980-2. PubMed ID: 26206899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women.
    Tabatabaie A; Karimi Zarchi M; Dehghani-Tafti M; Miratashi-Yazdi A; Teimoori S; Dehghani A
    Eur J Gynaecol Oncol; 2013; 34(6):552-5. PubMed ID: 24601050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could body mass index be an indicator for endometrial biopsy in premenopausal women with heavy menstrual bleeding?
    Guraslan H; Dogan K; Kaya C; Senturk MB; Guraslan B; Helvacioglu C; Akbayir O; Yasar L
    Arch Gynecol Obstet; 2016 Aug; 294(2):395-402. PubMed ID: 26895636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia.
    Bitto A; Granese R; Triolo O; Villari D; Maisano D; Giordano D; Altavilla D; Marini H; Adamo EB; Nicotina PA; D'Anna R; Squadrito F
    Phytomedicine; 2010 Sep; 17(11):844-50. PubMed ID: 20570122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.
    Gallos ID; Shehmar M; Thangaratinam S; Papapostolou TK; Coomarasamy A; Gupta JK
    Am J Obstet Gynecol; 2010 Dec; 203(6):547.e1-10. PubMed ID: 20934679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.
    Orbo A; Arnes M; Pettersen I; Larsen K; Hanssen K; Moe B
    Acta Obstet Gynecol Scand; 2010 Nov; 89(11):1438-46. PubMed ID: 20955098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.